This blog provides a medico-legal framework for evaluating GLP-1 claims, with a focus on evidentiary standards, medical analysis, and litigation strategy
Here are some of the potential side effects and possible risks
Panjwani N, Mulvihill EE, Longuet C, Yusta B, Campbell JE, Brown TJ, Streutker C, Holland D, Cao X, Baggio LL, et al: GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE/ Mice
It also improves blood vessel integrity through stimulation of collagen and elastin synthesis within vessel walls
For a long time, the manifestation of depressive symptoms has been also associated with the deficits in neurotrophic factor action in the brain [51], especially highlighting the role of diminished brain-derived neurotrophic factor (BDNF) signaling as important for the pathogenesis of this mental disorder [52]